EuKedos Past Earnings Performance
Past criteria checks 5/6
EuKedos has been growing earnings at an average annual rate of 32.9%, while the Healthcare industry saw earnings growing at 14.8% annually. Revenues have been declining at an average rate of 1.2% per year. EuKedos's return on equity is 2.4%, and it has net margins of 1.4%.
Key information
32.9%
Earnings growth rate
32.9%
EPS growth rate
Healthcare Industry Growth | 16.7% |
Revenue growth rate | -1.2% |
Return on equity | 2.4% |
Net Margin | 1.4% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
The Returns At EuKedos (BIT:EUK) Aren't Growing
Mar 15EuKedos (BIT:EUK) Seems To Be Using A Lot Of Debt
Oct 14EuKedos (BIT:EUK) Is Doing The Right Things To Multiply Its Share Price
Aug 10Is EuKedos (BIT:EUK) Using Too Much Debt?
May 03Here's What To Make Of EuKedos' (BIT:EUK) Decelerating Rates Of Return
Mar 07EuKedos (BIT:EUK) Seems To Be Using A Lot Of Debt
Oct 30Some Investors May Be Worried About EuKedos' (BIT:EUK) Returns On Capital
Sep 04Here's Why EuKedos (BIT:EUK) Is Weighed Down By Its Debt Load
May 06Would EuKedos S.p.A. (BIT:EUK) Be Valuable To Income Investors?
Mar 22Our Take On EuKedos' (BIT:EUK) CEO Salary
Dec 07Revenue & Expenses Breakdown
How EuKedos makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 51 | 1 | 0 | 0 |
31 Mar 24 | 50 | 1 | 0 | 0 |
31 Dec 23 | 49 | 1 | 0 | 0 |
30 Sep 23 | 49 | 0 | 0 | 0 |
30 Jun 23 | 48 | 0 | 0 | 0 |
31 Mar 23 | 48 | 0 | 0 | 0 |
31 Dec 22 | 47 | 0 | 0 | 0 |
30 Sep 22 | 47 | 1 | 0 | 0 |
30 Jun 22 | 47 | 1 | 0 | 0 |
31 Mar 22 | 46 | 1 | 0 | 0 |
31 Dec 21 | 45 | 1 | 0 | 0 |
30 Sep 21 | 44 | 0 | 0 | 0 |
30 Jun 21 | 44 | -1 | 0 | 0 |
31 Mar 21 | 45 | -1 | 0 | 0 |
31 Dec 20 | 47 | -2 | 0 | 0 |
30 Sep 20 | 49 | -1 | 0 | 0 |
30 Jun 20 | 51 | -1 | 0 | 0 |
31 Mar 20 | 52 | 0 | 0 | 0 |
31 Dec 19 | 53 | 1 | 0 | 0 |
30 Sep 19 | 53 | 1 | 2 | 0 |
30 Jun 19 | 52 | 1 | 4 | 0 |
31 Mar 19 | 52 | 1 | 5 | 0 |
31 Dec 18 | 52 | 1 | 7 | 0 |
30 Sep 18 | 51 | 0 | 7 | 0 |
30 Jun 18 | 51 | -2 | 7 | 0 |
31 Mar 18 | 51 | -2 | 7 | 0 |
31 Dec 17 | 51 | -2 | 7 | 0 |
30 Sep 17 | 50 | -1 | 7 | 0 |
30 Jun 17 | 50 | 0 | 7 | 0 |
31 Mar 17 | 50 | 0 | 6 | 0 |
31 Dec 16 | 49 | 0 | 6 | 0 |
30 Sep 16 | 52 | -1 | 7 | 0 |
30 Jun 16 | 55 | -1 | 7 | 0 |
31 Mar 16 | 57 | -1 | 7 | 0 |
31 Dec 15 | 59 | -1 | 7 | 0 |
30 Sep 15 | 57 | -1 | 7 | 0 |
30 Jun 15 | 54 | -1 | 7 | 0 |
31 Mar 15 | 56 | 0 | 7 | 0 |
31 Dec 14 | 58 | 0 | 7 | 0 |
30 Sep 14 | 61 | 0 | 6 | 0 |
30 Jun 14 | 64 | 0 | 6 | 0 |
31 Mar 14 | 67 | 0 | 6 | 0 |
31 Dec 13 | 70 | 0 | 6 | 0 |
Quality Earnings: EUK has high quality earnings.
Growing Profit Margin: EUK's current net profit margins (1.4%) are higher than last year (0.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EUK has become profitable over the past 5 years, growing earnings by 32.9% per year.
Accelerating Growth: EUK's earnings growth over the past year (76.2%) exceeds its 5-year average (32.9% per year).
Earnings vs Industry: EUK earnings growth over the past year (76.2%) exceeded the Healthcare industry -8.6%.
Return on Equity
High ROE: EUK's Return on Equity (2.4%) is considered low.